...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155


BREAKING: Spyder Cannabis Announces Plans to Enter US Hemp Derived Market Through Rollout of Boutique Retail and Kiosk Stores

  • Newly Listed Spyder Cannabis $SPDR.ca Announces Phase 1 plan for locations in 4 states
  • Already an established Ontario retail operator
  • Partnering with developers & realtors for prime real estate high traffic areas (Malls, Sport Venues)

Spdr logo large

Hub On AGORACOM / Read Release

Message: DSMB 7th review??

This is one time I'd very much like to be wrong, its just the feeling I get based on the way the cancelling of the Futility Analysis was handled...or not handled as the case may be.  

Don struck me as very confident during his presentation in May when he said that BETonMACE is "properly powered".  I know Bear has highlighted how an SSRA is more than just a report on the "powering" (for lack of a better word) of a trial....but for me that would be the only real data point I'd be interested in at this point.  

New Message
Please login to post a reply